tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating on Annexon Biosciences: Promising ANX005 for GBS and Strategic Path to FDA Approval
PremiumRatingsBuy Rating on Annexon Biosciences: Promising ANX005 for GBS and Strategic Path to FDA Approval
2M ago
Annexon price target lowered to $14 from $20 at H.C. Wainwright
Premium
The Fly
Annexon price target lowered to $14 from $20 at H.C. Wainwright
2M ago
Annexon Biosciences: Promising Growth Potential with Key Catalysts and Strategic FDA Interactions
Premium
Ratings
Annexon Biosciences: Promising Growth Potential with Key Catalysts and Strategic FDA Interactions
2M ago
Annexon Biosciences’ ANX005: Promising Phase III Results and Strategic Initiatives Drive Buy Rating
PremiumRatingsAnnexon Biosciences’ ANX005: Promising Phase III Results and Strategic Initiatives Drive Buy Rating
4M ago
Annexon announces tanruprubart trial meets primary endpoint
Premium
The Fly
Annexon announces tanruprubart trial meets primary endpoint
4M ago
Needham healthcare analysts hold analyst/industry conference call
Premium
The Fly
Needham healthcare analysts hold analyst/industry conference call
4M ago
Annexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating
PremiumRatingsAnnexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating
5M ago
Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating
Premium
Ratings
Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating
5M ago
Promising Potential of Annexon Biosciences’ ANX1502 Drives Buy Rating Amid Positive Clinical Data
Premium
Ratings
Promising Potential of Annexon Biosciences’ ANX1502 Drives Buy Rating Amid Positive Clinical Data
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100